Search

everythinglearnresearchcommunity

for

Search:↓

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Stopping valproate and using lactulose can quickly treat valproate-induced hyperammonemia.

The new gel effectively treats MRSA-infected wounds for longer.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Spanlastics are effective for delivering Meloxicam with improved stability and targeting.

Spanlastics can improve drug delivery by effectively penetrating biological membranes.

Trilostane may help delay epilepsy development by increasing certain brain chemicals.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.

The metoprolol-spironolactone combination improves heart function in patients with coronary heart disease and heart failure.

Strontium ranelate is no longer available for treatment.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Spanlastics improve drug delivery by enhancing bioavailability and targeting, reducing side effects.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.

Calancardin B may help reduce inflammation in immune cells.